Overview: Serum-Ascites Albumin Gradient (SAAG) Panel
Introduction: The Serum-Ascites Albumin Gradient (SAAG) Panel is a diagnostic tool designed to assess ascites cause using paired serum and ascites samples. In India, ascites is common in cirrhosis (~50 percent of decompensated liver disease), portal hypertension, peritoneal carcinomatosis, and TB peritonitis; SAAG >1.1 g/dL indicates portal hypertension (cirrhosis, heart failure). High morbidity from under-testing in rural/low-SES patients with abdominal distension, limited labs, delayed diuretics or paracentesis leading to spontaneous bacterial peritonitis or misdiagnosis. Per gastroenterology practices aligned with ICMR and Indian Society of Gastroenterology guidelines, the test employs spectrophotometry for serum albumin, ascites albumin, and SAAG calculation over 1-2 days with high accuracy, valuable for differentiating transudative vs exudative ascites. This diagnostic falls under liver/renal screening and targets patients with new-onset ascites or decompensated liver disease, addressing accurate detection to guide diuretics, salt restriction, or diagnostic paracentesis. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise ascites etiology assessment and reducing complications. Its paired sample-based approach ensures reliable gradient calculation.
Other Names: SAAG Pnl.
FDA Status: FDA approved, CLIA certified for biochemistry/clinical pathology, compliant with 2025 standards.
Historical Milestone: SAAG standard since 1980s; in India, routine in hepatology.
Purpose: The test assesses 3 parameters including serum albumin to guide ascites cause assessment, calculate SAAG, inform therapy.
Test Parameters: 1. Serum Albumin, 2. Ascites Albumin, 3. SAAG.
Pretest Condition: No fasting required; patients should have ascites.
Specimen: 3 mL serum in 1 SST + 2 mL ascites in sterile container, transported within specified times to maintain sample viability.
Sample Stability at Room Temperature: Serum: 8 hours, Ascites: 24 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.
Sample Stability at Refrigeration: Serum: 7 days, Ascites: 48 hours at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: Serum: 6 months, Ascites: â€" at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.
Medical History: Patients should provide details on liver disease, abdominal distension.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of undetected ascites cause including SBP, benefits of screening, and minimal discomfort from sampling/paracentesis.
Procedural Considerations: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and calculate SAAG within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: SAAG >1.1 g/dL indicates portal hypertension; <1.1 g/dL suggests peritoneal disease, necessitating specialist input.
Specialist Consultation: Hepatologists or gastroenterologists should be consulted for management.
Additional Supporting Tests: Ascites fluid analysis, culture for SBP.
Test Limitations: Requires paired samples; comprehensive approach required.
References: Indian Journal of Gastroenterology 2024, Hepatology Studies India 2023.
